The safety and efficacy of Houtou Jianweiling tablet in patients with chronic non-atrophic gastritis: a double-blind, non-inferiority, randomized controlled trial

• Egile Nagusiak: Muhammad Raza Shah (Egilea), Samreen Fatima (Egilea), Sehrosh Naz Khan (Egilea), Shafiullah (Egilea), Zahid Azam (Egilea), Hafeezullah Shaikh (Egilea), Shahid Majid (Egilea), He Chengdong (Egilea), Zhou Daijun (Egilea), Wei Wang (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Common symptoms of Chronic Non-atrophic Gastritis (CNAG) include nausea, stomach distension, and abdominal pain. The Houtou Jianweiling Tablet (HTJWT) is a chinese patent medicine (CN1368229A) and it has been used clinically for more than 20 years with proven clinical efficacy in treatin...